table of content
1 Introduction to Research & Analysis Reports
1.1 Biosimilar Testing and Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Biosimilar Testing and Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Biosimilar Testing and Development Services Overall Market Size
2.1 Global Biosimilar Testing and Development Services Market Size: 2021 VS 2028
2.2 Global Biosimilar Testing and Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Biosimilar Testing and Development Services Players in Global Market
3.2 Top Global Biosimilar Testing and Development Services Companies Ranked by Revenue
3.3 Global Biosimilar Testing and Development Services Revenue by Companies
3.4 Top 3 and Top 5 Biosimilar Testing and Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Biosimilar Testing and Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Biosimilar Testing and Development Services Players in Global Market
3.6.1 List of Global Tier 1 Biosimilar Testing and Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Biosimilar Testing and Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Biosimilar Testing and Development Services Market Size Markets, 2021 & 2028
4.1.2 Effector Binding
4.1.3 ELISA
4.1.4 Kinetic Binding Assays
4.1.5 ADCC & CDC Cell-Based Assays
4.2 By Type - Global Biosimilar Testing and Development Services Revenue & Forecasts
4.2.1 By Type - Global Biosimilar Testing and Development Services Revenue, 2017-2022
4.2.2 By Type - Global Biosimilar Testing and Development Services Revenue, 2023-2028
4.2.3 By Type - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Biosimilar Testing and Development Services Market Size, 2021 & 2028
5.1.2 PK assay
5.1.3 Tiered Immunogenicity testing
5.1.4 NAb assays
5.2 By Application - Global Biosimilar Testing and Development Services Revenue & Forecasts
5.2.1 By Application - Global Biosimilar Testing and Development Services Revenue, 2017-2022
5.2.2 By Application - Global Biosimilar Testing and Development Services Revenue, 2023-2028
5.2.3 By Application - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Biosimilar Testing and Development Services Market Size, 2021 & 2028
6.2 By Region - Global Biosimilar Testing and Development Services Revenue & Forecasts
6.2.1 By Region - Global Biosimilar Testing and Development Services Revenue, 2017-2022
6.2.2 By Region - Global Biosimilar Testing and Development Services Revenue, 2023-2028
6.2.3 By Region - Global Biosimilar Testing and Development Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Biosimilar Testing and Development Services Revenue, 2017-2028
6.3.2 US Biosimilar Testing and Development Services Market Size, 2017-2028
6.3.3 Canada Biosimilar Testing and Development Services Market Size, 2017-2028
6.3.4 Mexico Biosimilar Testing and Development Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Biosimilar Testing and Development Services Revenue, 2017-2028
6.4.2 Germany Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.3 France Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.4 U.K. Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.5 Italy Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.6 Russia Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.7 Nordic Countries Biosimilar Testing and Development Services Market Size, 2017-2028
6.4.8 Benelux Biosimilar Testing and Development Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Biosimilar Testing and Development Services Revenue, 2017-2028
6.5.2 China Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.3 Japan Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.4 South Korea Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.5 Southeast Asia Biosimilar Testing and Development Services Market Size, 2017-2028
6.5.6 India Biosimilar Testing and Development Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Biosimilar Testing and Development Services Revenue, 2017-2028
6.6.2 Brazil Biosimilar Testing and Development Services Market Size, 2017-2028
6.6.3 Argentina Biosimilar Testing and Development Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Biosimilar Testing and Development Services Revenue, 2017-2028
6.7.2 Turkey Biosimilar Testing and Development Services Market Size, 2017-2028
6.7.3 Israel Biosimilar Testing and Development Services Market Size, 2017-2028
6.7.4 Saudi Arabia Biosimilar Testing and Development Services Market Size, 2017-2028
6.7.5 UAE Biosimilar Testing and Development Services Market Size, 2017-2028
7 Players Profiles
7.1 Eurofins Scientific
7.1.1 Eurofins Scientific Corporate Summary
7.1.2 Eurofins Scientific Business Overview
7.1.3 Eurofins Scientific Biosimilar Testing and Development Services Major Product Offerings
7.1.4 Eurofins Scientific Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.1.5 Eurofins Scientific Key News
7.2 SGS
7.2.1 SGS Corporate Summary
7.2.2 SGS Business Overview
7.2.3 SGS Biosimilar Testing and Development Services Major Product Offerings
7.2.4 SGS Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.2.5 SGS Key News
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Corporate Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Biosimilar Testing and Development Services Major Product Offerings
7.3.4 Charles River Laboratories Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.3.5 Charles River Laboratories Key News
7.4 Pharmaceutical Product Development
7.4.1 Pharmaceutical Product Development Corporate Summary
7.4.2 Pharmaceutical Product Development Business Overview
7.4.3 Pharmaceutical Product Development Biosimilar Testing and Development Services Major Product Offerings
7.4.4 Pharmaceutical Product Development Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.4.5 Pharmaceutical Product Development Key News
7.5 Exova
7.5.1 Exova Corporate Summary
7.5.2 Exova Business Overview
7.5.3 Exova Biosimilar Testing and Development Services Major Product Offerings
7.5.4 Exova Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.5.5 Exova Key News
7.6 Source BioScience
7.6.1 Source BioScience Corporate Summary
7.6.2 Source BioScience Business Overview
7.6.3 Source BioScience Biosimilar Testing and Development Services Major Product Offerings
7.6.4 Source BioScience Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.6.5 Source BioScience Key News
7.7 Intertek Group
7.7.1 Intertek Group Corporate Summary
7.7.2 Intertek Group Business Overview
7.7.3 Intertek Group Biosimilar Testing and Development Services Major Product Offerings
7.7.4 Intertek Group Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.7.5 Intertek Group Key News
7.8 Medistri
7.8.1 Medistri Corporate Summary
7.8.2 Medistri Business Overview
7.8.3 Medistri Biosimilar Testing and Development Services Major Product Offerings
7.8.4 Medistri Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.8.5 Medistri Key News
7.9 Pace Analytical Services
7.9.1 Pace Analytical Services Corporate Summary
7.9.2 Pace Analytical Services Business Overview
7.9.3 Pace Analytical Services Biosimilar Testing and Development Services Major Product Offerings
7.9.4 Pace Analytical Services Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.9.5 Pace Analytical Services Key News
7.10 Sigma-Aldrich
7.10.1 Sigma-Aldrich Corporate Summary
7.10.2 Sigma-Aldrich Business Overview
7.10.3 Sigma-Aldrich Biosimilar Testing and Development Services Major Product Offerings
7.10.4 Sigma-Aldrich Biosimilar Testing and Development Services Revenue in Global Market (2017-2022)
7.10.5 Sigma-Aldrich Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
